Showing results (141-150 of 370) with videos related to

Sort By:
Pageof 37
The Journal of Rheumatology|January 6, 2004
Etanercept in the treatment of patients with primary Sjögren's syndrome: a pilot studyMichiel M Zandbelt, Peter de Wilde, Philip van Damme, et al.
Neuromuscular Disorders : NMD|February 1, 2016
How robust is ACTIVLIM for the follow-up of activity limitations in patients with neuromuscular diseases?Charles Sèbiyo Batcho, Peter Y K Van den Bergh, Philip Van Damme, et al.
Human Brain Mapping|May 1, 2009
Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: revisitedCaroline A Sage, Wim Van Hecke, Ronald Peeters, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 21, 2025
Support vector machine classification of 18F-FDG PET scans across subtypes of amyotrophic lateral sclerosisChunmeng Tang, Juliette Foucher, Linn Öijerstedt, et al.
Cell Death & Disease|March 15, 2026
Human FUS is toxic via association with RNA polymerase II in DrosophilaThomas G Moens, Luca Biasetti, Wendy Scheveneels, et al.
Acta Neurologica Belgica|February 13, 2019
Clinical spectrum of the anti-GQ1b antibody syndrome: a case series of eight patientsAlexander de Bruyn, Koen Poesen, Xavier Bossuyt, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 9, 2026
18F FDG-PET correlates of motor neuron disease motor variantsBoris Deleu, Patrick Dupont, Kato Bracaval, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trialsVincent Meininger, Gilbert Bensimon, Walter R Bradley, et al.
Human Molecular Genetics|December 10, 2019
Environmental enrichment during the chronic phase after experimental stroke promotes functional recovery without synergistic effects of EphA4 targeted therapyAntina de Boer, Annet Storm, Maricel Gomez-Soler, et al.
Human Molecular Genetics|July 20, 2007
Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafishRobin Lemmens, Annelies Van Hoecke, Nicole Hersmus, et al.
Pageof 37